| Jimmy Robert Klugh, | |
|
460 Washington Rd, Suite 7, Washington, PA 15301-2765 | |
| (724) 225-3627 | |
| (304) 598-3630 |
| Full Name | Jimmy Robert Klugh |
|---|---|
| Gender | Male |
| Speciality | |
| Experience | Years |
| Location | 460 Washington Rd, Washington, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912906082 | NPI | - | NPPES |
| KL1689021 | Other | PA | HIGHMARK BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | MD425430 (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jimmy Robert Klugh, 460 Washington Rd, Suite 7, Washington, PA 15301-2765 Ph: (724) 225-3627 | Jimmy Robert Klugh, 460 Washington Rd, Suite 7, Washington, PA 15301-2765 Ph: (724) 225-3627 |
News Archive
Aradigm Corporation today announced that it dosed the first patient in the U.S. as part of its ORBIT-1 (Once-daily Respiratory Bronchiectasis Inhalation Treatment) trial, an international, randomized, double-blind, placebo-controlled Phase 2b study designed to evaluate the Company's inhaled liposomal ciprofloxacin (ARD-3100) in patients with non-cystic fibrosis bronchiectasis (BE) under a U.S. IND. This orphan disease indication is a chronic, severe respiratory disease and there are currently no approved treatments for this disease in the U.S.
Relmada Therapeutics Inc., a clinical-stage company developing novel therapies for the treatment of chronic pain, today announced a positive outcome of its pivotal pharmacokinetic study for LevoCap ER. Based on the positive outcome of this study, Relmada is now preparing the Phase III development program and is planning to submit a request with the FDA to discuss the final pathway to the New Drug Application for this product during the fourth quarter of this year.
News outlets report on the efforts by states, navigators, organizations and others to help uninsured people find their way through the challenges of applying for health insurance on the new online marketplaces.
It is widely known that mutations in the breast cancer susceptibility 1 (BRCA1) gene significantly increase the chance of developing breast and ovarian cancers, but the mechanisms at play are not fully understood. Now, researchers at Virginia Commonwealth University Massey Cancer Center have shown that certain BRCA1 mutations result in excessive, uncontrolled DNA repair, which challenges the prior assumption that mutations in BRCA1 only contribute to breast cancer through a reduction in function.
› Verified 7 days ago
Dr. Dena R Nader, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 155 Wilson Avenue, The Washington Hospital, Washington, PA 15301 Phone: 724-223-3342 Fax: 610-617-6280 | |
Julieanne Renee Watters, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 155 Wilson Ave, Washington Hospital, Washington, PA 15301 Phone: 724-223-3342 Fax: 610-617-6280 | |
Vinod Chettur, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 155 Wilson Ave, The Washington Hospital, Washington, PA 15301 Phone: 724-223-3342 | |
Guy Avolio, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 460 Washington Rd, Suite 7, Washington, PA 15301 Phone: 724-225-3627 Fax: 304-598-3630 | |
Dr. David Vincent Fuchs, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 155 Wilson Ave, The Washington Hospital, Washington, PA 15301 Phone: 724-223-3342 Fax: 610-617-6280 | |
Rene Julio Moncion, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 24 Stonehenge Dr, Washington, PA 15301 Phone: 757-613-1936 | |
Ms. Lori B Jenkins, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 155 Wilson Ave, Washington, PA 15301 Phone: 724-223-3085 |